Associate Professor Janette Burgess

NHMRC Career Development Fellow
Pharmacology, School of Medical Sciences
Woolcock Institute of Medical Research

Telephone 9114 0368
Fax 9114 0399

Map

Research interests

Associate Professor Janette Burgess is one of the international principal pioneers of the work on the extracellular matrix - its role in airway disease- its interaction with structural lung cells, and the potential for pharmacological intervention. Her particular area of expertise is the molecular and cellular biology of lung disease.

PhD and master's project opportunities

Selected grants

2014

  • The central role of Connective Tissue Growth Factor in remodelling of asthmatic airways; Burgess J, Ashton A; National Health and Medical Research Council (NHMRC)/Project Grants.
  • CLARIOstar Multifunctional Microplate Reader for Shared Used at the Open Access, Multi-User Molecular Biology Core Facility; Huang M, Scolyer R, Fraser S, Sahni S, Speranza T, Owens T, Barrs V, Ju Y, Kovacevic Z, Lu Z, Camp A, Slobedman B, Morris B, Oliver B, Dos Remedios C, Kalinowski D, Fu D, Lai D, Lovicu F, Allbutt H, Triccas J, Burgess J, Kril J, Dixon K, Rendina L, Byrne M, King N, Groundwater P, Williamson P, Ho J, Dong Q, Bao B, Assinder S, McLennan S, Richardson D, Ammit A, Sharland A, Hardikar A, Hong A, Hambly B, Lee C, Murphy C, Goldsbury C, Johnstone D, Lane D, Hibbs D, Joshua D, Huq F, Halliday G, Sutherland G, Zreiqat H, Lok H, Lyons G, Jansson P, Black J, Zhu L, Sunde M, Day M, Naylor M, Buckland M, Murray M, Shafie N, Lay P, Poronnik P, Codd R, Mason R, Ryan R, Christopherson R, de Graaf S; National Health and Medical Research Council (NHMRC)/Equipment Grants.
  • Using Electric Cell-substrate Impedance to explore the regulation of angiogenesis in asthma; Burgess J, Oliver B, Young P; Rebecca L Cooper Medical Research Foundation/Equipment Grant.

2013

  • Role of CP17, a collagen IV matrikine, in neutrophilic asthma; Burgess J; Group of Eight/Germany Joint Research Co-operation Scheme.
  • nanoIR - nanoscale bioimaging with continuous mapping of chemical and physical properties; Gomes V, Dehghani F, Gan Y, Chang L, Jabbarzadeh-Khoei A, McKenzie D, Hanaor D, Zhou F, Chrzanowski W, Braet F, Bilek M, Chan H, Perrier S, O'Neill G, Ammit A, Brand-Miller J, McEwan A, Hawkett B, Kondyurin A, Li Q, Burgess J, Li Z; National Health and Medical Research Council (NHMRC)/Equipment Grants.
  • QX100 Droplet Digital PCR system for Shared Used at the Open Access, Multi-User Molecular Biology Core Facility; Richardson D, Kril J, Murphy C, Vandenberg R, Rendina L, Dos Remedios C, Ju Y, Kovacevic Z, Lyons G, Sutherland G, Lay P, Ammit A, Lai D, Morris B, Day M, Dong Q, Bao B, Huang M, Camp A, Boyer M, Whittington R, Byrne M, Hanrahan J, Fu D, Jansson P, Lane D, Bagley E, Hibbs D, Zhang D, Fraser S, Scolyer R, Black J, Halliday G, Christie M, Zreiqat H, Murray M, Slobedman B, Naylor M, Burgess J, Triccas J, Mason R, Chadban S, Combes V, Lovicu F, McLennan S, Kalinowski D, Sharland A, Johnstone D, Groundwater P, Dixon K, Zhou F, Lovejoy D, Lu Z, Zhu L, Goldsbury C, Witting P, Buckland M, Assinder S, Purdie (Williams) A, Codd R, Owens T, Hambly B; National Health and Medical Research Council (NHMRC)/Equipment Grants.

2012

  • Understanding structural changes in the lung; Burgess J; National Health and Medical Research Council (NHMRC)/Career Development Fellowship.

2011

  • Airway smooth muscle cell interactions; Burgess J; DVC Research/Bridging Support Grant.
  • Fibulin-a target for lung fibrosis?; Black J, Burgess J, Hansbro P; National Health and Medical Research Council (NHMRC)/Project Grants.

2010

  • Mast cells- bystanders or instigators of airway remodelling in asthma?; Hughes M, Brightling C, Burgess J, Armour C; National Health and Medical Research Council (NHMRC)/Project Grants.

2009

  • The anti-inflammatory role of collagen VI in asthma; Burgess J, Oliver B, Weckmann M; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Interaction of CTFG and VEGF: a co-partner binding model regulating blood vessel formation; Burgess J; DVC Research/Bridging Support Grant.
  • Nikon Eclipse Ti-E PFS research grade inverted microscope and accessories; Black J, Burgess J; Rebecca L Cooper Medical Research Foundation/Equipment Grant.

2008

  • Signal transduction in airway remodelling; Black J, Oliver B, Burgess J; National Health and Medical Research Council (NHMRC)/Project Grants.

2007

  • Airway smooth muscle control of mast cells in asthma; Brightling C, Hughes M, Brightling C, Ammit A, Burgess J, Armour C; National Health and Medical Research Council (NHMRC)/Project Grants.

2006

  • Mechanisms Of Airway Remodelling In Asthma; Burgess J; National Health and Medical Research Council (NHMRC)/Established Career Fellowships.

2005

  • Characterisation of the release of PGE2 from asthmatic & nonasthmatic epitgelial cells; Burgess J; Asthma Foundation of NSW/Research Grants.
  • Airway hyperresponsiveness - Cellular molecular mechanisms.; Johnson P, Burgess J, Roth M; Asthma Foundation of NSW/Research Grants.
  • Defining the abnormalities in asthmatic airway smooth muscle; Black J, Burgess J; University of Sydney/Research & Development.

2003

  • Cellular and molecular mechanisms in fibroproliferative lung disease; Johnson P, Burgess J, Black J; Rebecca L Cooper/Medical Research Foundation.

2002

  • Mechanisms of airway remodelling in asthma; National Health and Medical Research Council (NHMRC)/Established Career Fellowships.

2000

  • Matrix regulation and remodelling in asthmatic airways; Black J, Burgess J; Clive & Vera Ramaciotti Foundation/Research Grant.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Black, J., Burgess, J., Oliver, B., Moir, L. (2008). Altered properties of airway smooth muscle in asthma. In Chung, K. (Eds.), Airway Smooth Muscle in Asthma and COPD: Biology and Pharmacology, (pp. 181-199). United Kingdom: John Wiley & Sons.
  • Burgess, J. (2004). Overview Of Microarrays In Genomic Analysis. In Ralph Rapley, Harbron Stuart (Eds.), Molecular Analysis and Genome Discovery, (pp. 127-158). UK: Nicholson Museum, University of Sydney.

Journals

  • Grafton, K., Moir, L., Black, J., Hansbro, N., Hansbro, P., Burgess, J., Oliver, B. (2014). LF-15 and T7, Synthetic Peptides Derived from Tumstatin, Attenuate Aspects of Airway Remodelling in a Murine Model of Chronic OVA-Induced Allergic Airway Disease. PLoS One, 9(1), 1-6. [More Information]
  • Tjin, G., Xu, P., Kable, S., Kable, E., Burgess, J. (2014). Quantification of collagen I in airway tissues using second harmonic generation. Journal of Biomedical Optics, 19(3), 1-10. [More Information]
  • Van Ly, D., Faiz, A., Jenkins, C., Crossett, B., Black, J., McParland, B., Burgess, J., Oliver, B. (2013). Characterising the Mechanism of Airway Smooth Muscle B2 Adrenoceptor Desensitization by Rhinovirus Infected Bronchial Epithelial Cells. PLoS One, 8(2), 1-17. [More Information]
  • Chen, L., Ge, Q., Black, J., Deng, L., Burgess, J., Oliver, B. (2013). Differential Regulation of Extracellular Matrix and Soluble Fibulin-1 Levels by TGF-β1 in Airway Smooth Muscle Cells. PLoS One, 8(6), 1-8. [More Information]
  • Krimmer, D., Ichimaru, Y., Burgess, J., Black, J., Oliver, B. (2013). Exposure to Biomass Smoke Extract Enhances Fibronectin Release from Fibroblasts. PLoS One, 8(12), 1-10. [More Information]
  • Wright, D., Trian, T., Siddiqui, S., Pascoe, C., Ojo, O., Johnson, J., Dekkers, B., Dakshinamurti, S., Bagchi, R., Burgess, J., et al (2013). Functional phenotype of airway myocytes from asthmatic airways. Pulmonary Pharmacology & Therapeutics, 26(1), 95-104. [More Information]
  • Van Ly, D., De Pedro, M., James, P., Morgan, L., Black, J., Burgess, J., Oliver, B. (2013). Inhibition of phosphodiesterase 4 modulates cytokine induction from toll like receptor activated, but not rhinovirus infected, primary human airway smooth muscle. Respiratory Research (Online), 14(127), 1-11. [More Information]
  • Wright, D., Trian, T., Siddiqui, S., Pascoe, C., Johnson, J., Dekkers, B., Dakshinamurti, S., Bagchi, R., Burgess, J., Kanabar, V., et al (2013). Phenotype modulation of airway smooth muscle in asthma. Pulmonary Pharmacology & Therapeutics, 26(1), 42-49. [More Information]
  • Faiz, A., Tjin, G., Harkness, L., Weckmann, M., Bao, B., Black, J., Oliver, B., Burgess, J. (2013). The Expression and Activity of Cathepsins D, H and K in Asthmatic Airways. PLoS One, 8(3), 1-8. [More Information]
  • Reddel, C., Cultrone, D., Rnjak-Kovacina, J., Weiss, A., Burgess, J. (2013). Tropoelastin modulates TGF-B1-induced expression of VEGF and CTGF in airway smooth muscle cells. Matrix biology: journal of the International Society for Matrix Biology, 32(7-8), 407-413. [More Information]
  • Alrashdan, Y., Alkhouri, H., Chen, E., Lalor, D., Poniris, M., Henness, S., Brightling, C., Burgess, J., Armour, C., Ammit, A., Hughes, M. (2012). Asthmatic airway smooth muscle CXCL10 production: mitogen-activated protein kinase JNK involvement. American Journal of Physiology: Lung Cellular and Molecular Physiology, 302(10), L118-L1127. [More Information]
  • Niimi, K., Ge, Q., Moir, L., Ammit, A., Trian, T., Burgess, J., Black, J., Oliver, B. (2012). B2-Agonists upregulate PDE4 mRNA but not protein or activity in human airway smooth muscle cells from asthmatic and nonasthmatic volunteers. American Journal of Physiology: Lung Cellular and Molecular Physiology, 302(3), L334-L342. [More Information]
  • Ge, Q., Poniris, M., Moir, L., Black, J., Burgess, J. (2012). Combined Beta-Agonists and Corticosteroids Do Not Inhibit Extracellular Matrix Protein Production In Vitro. Journal of Allergy, 2012, 1-7. [More Information]
  • Bosse, Y., Vagula, M., Pun, M., Black, J., Berger, P., Rawding, R., Burgess, J., Adner, M., Oliver, B., Marthan, R. (2012). Comments on Point:Counterpoint: Alterations in airway smooth muscle phenotype do/do not cause airway hyperresponsiveness in asthma. Journal of Applied Physiology, 113(5), 844-846. [More Information]
  • Reddel, C., Weiss, A., Burgess, J. (2012). Elastin in asthma. Pulmonary Pharmacology & Therapeutics, 25(2), 144-153. [More Information]
  • Faiz, A., Burgess, J. (2012). How Can Microarrays Unlock Asthma? Journal of Allergy, 2012, 1-15. [More Information]
  • Baraket, M., Oliver, B., Burgess, J., Lim, S., King, G., Black, J. (2012). Is low dose inhaled corticosteroid therapy as effective for inflammation and remodeling in asthma? A randomized, parallel group study. Respiratory Research (Online), 13(2 February 2012), 1-11. [More Information]
  • Weckmann, M., Moir, L., Heckman, C., Black, J., Oliver, B., Burgess, J. (2012). Lamstatin - a novel inhibitor of lymphangiogenesis derived from collagen IV. Journal of Cellular and Molecular Medicine, 16(12), 3062-3073. [More Information]
  • Burgess, J., Weckmann, M. (2012). Matrikines and the lungs. Pharmacology & Therapeutics, 134(3), 317-337. [More Information]
  • Krimmer, D., Burgess, J., Wooi, T., Black, J., Oliver, B. (2012). Matrix Proteins from Smoke Exposed Fibroblasts are Pro-proliferative. American Journal of Respiratory Cell and Molecular Biology, 46(1), 34-39. [More Information]
  • Van Ly, D., Burgess, J., Brock, T., Lee, T., Black, J., Oliver, B. (2012). Prostaglandins but not leukotrienes alter extracellular matrix protein deposition and cytokine release in primary human airway smooth muscle cells and fibroblasts. American Journal of Physiology: Lung Cellular and Molecular Physiology, 303(3), L239-L250. [More Information]
  • Ichimaru, Y., Krimmer, D., Burgess, J., Black, J., Oliver, B. (2012). TGF-B enhances deposition of perlecan from COPD airway smooth muscle. American Journal of Physiology: Lung Cellular and Molecular Physiology, 302(3), L325-L333. [More Information]
  • Ge, Q., Moir, L., Trian, T., Niimi, K., Poniris, M., Shepherd, P., Black, J., Oliver, B., Burgess, J. (2012). The phosphoinositide 3'-kinase p110d modulates contractile protein production and IL-6 release in human airway smooth muscle. Journal of Cellular Physiology, 227(8), 3044-3052. [More Information]
  • Seidel, P., Alkhouri, H., Lalor, D., Burgess, J., Armour, C., Hughes, M. (2012). Thiazolidinediones inhibit airway smooth muscle release of the chemokine CXCL10: in vitro comparison with current asthma therapies. Respiratory Research (Online), 13, 1-13. [More Information]
  • Burgess, J. (2011). Current and future models for understanding airway diseases. Pulmonary Pharmacology and Therapeutics, 24(5), 443-443. [More Information]
  • Moir, L., Ng, H., Poniris, M., Santa, T., Burgess, J., Oliver, B., Krymskaya, V., Black, J. (2011). Doxycycline inhibits matrix metalloproteinase-2 secretion from TSC2-null mouse embryonic fibroblasts and lymphangioleiomyomatosis cells. British Journal of Pharmacology, 164(1), 83-92. [More Information]
  • Van Ly, D., King, N., Moir, L., Burgess, J., Black, J., Oliver, B. (2011). Effects of β2 Agonists, Corticosteroids, and Novel Therapies on Rhinovirus-Induced Cytokine Release and Rhinovirus Replication in Primary Airway Fibroblasts. Journal of Allergy, 2011 (Article ID 457169), 1-11. [More Information]
  • Moir, L., Trian, T., Ge, Q., Shepherd, P., Burgess, J., Oliver, B., Black, J. (2011). Phosphatidylinositol 3-Kinase Isoform-Specific Effects in Airway Mesenchymal Cell Function. Journal of Pharmacology and Experimental Therapeutics, 337(2), 557-566. [More Information]
  • Kuo, C., Lim, S., King, N., Bartlett, N., Walton, R., Zhu, J., Glanville, N., Aniscenko, J., Johnston, S., Burgess, J., Black, J., Oliver, B. (2011). Rhinovirus infection induces expression of airway remodelling factors in vitro and in vivo. Respirology, 16(2), 367-377. [More Information]
  • Kuo, C., Lim, S., King, N., Johnston, S., Burgess, J., Black, J., Oliver, B. (2011). Rhinovirus infection induces extracellular matrix protein deposition in asthmatic and nonasthmatic airway smooth muscle cells. American Journal of Physiology: Lung Cellular and Molecular Physiology, 300(6), L951-L957. [More Information]
  • Trian, T., Burgess, J., Niimi, K., Moir, L., Ge, Q., Berger, P., Liggett, S., Black, J., Oliver, B. (2011). β(2)-Agonist Induced cAMP Is Decreased in Asthmatic Airway Smooth Muscle Due to Increased PDE4D. PLoS One, 6(5), e20000-1-e20000-7. [More Information]
  • Lau, J., Oliver, B., Moir, L., Black, J., Burgess, J. (2010). Differential expression of peroxisome proliferator activated receptor gamma and cyclin D1 does not affect proliferation of asthma- and non-asthma-derived airway smooth muscle cells. Respirology, 15(2), 303-312. [More Information]
  • Lau, J., Oliver, B., Baraket, M., Beckett, E., Hansbro, N., Moir, L., Wilton, S., Williams, C., Foster, P., Hansbro, P., Black, J., Burgess, J. (2010). Fibulin-1 is increased in asthma - a novel mediator of airway remodeling? PLoS One, 5(10 (e13360)), 1-13. [More Information]
  • Burgess, J., Boustany, S., Moir, L., Weckmann, M., Lau, J., Grafton, K., Baraket, M., Hansbro, P., Hansbro, N., Foster, P., Black, J., Oliver, B. (2010). Reduction of Tumstatin in Asthmatic Airways Contributes to Angiogenesis, Inflammation and Hyperresponsiveness. American Journal of Respiratory and Critical Care Medicine, 181(2), 106-115. [More Information]
  • Ge, Q., Moir, L., Black, J., Oliver, B., Burgess, J. (2010). TGFBeta1 Induces IL-6 and Inhibits IL-8 Release in Human Bronchial Epithelial Cells: The Role of Smad2/3. Journal of Cellular Physiology, 225(3), 846-854. [More Information]
  • Burgess, J. (2010). The Extracellular Matrix: Friend or Foe in Airway Disease? Minerva Pneumologica: A Journal on Diseases of the Respiratory System, 49, 219-236.
  • Bailey, S., Boustany, S., Burgess, J., Hirst, S., Sharma, H., Simcock, D., Suravaram, P., Weckmann, M. (2009). Airway vascular reactivity and vascularisation in human chronic airway disease. Pulmonary Pharmacology and Therapeutics, 22(5), 417-425. [More Information]
  • Krimmer, D., Loseli, M., Hughes, M., Oliver, B., Moir, L., Hunt, N., Black, J., Burgess, J. (2009). CD40 and OX40 ligand are differentially regulated on asthmatic airway smooth muscle. Allergy, 64, 1074-1082. [More Information]
  • Fukuyama, S., Nakano, T., Matsumoto, T., Oliver, B., Burgess, J., Moriwaki, A., Tanaka, K., Kubo, M., Hoshino, T., Tanaka, H., Black, J., et al (2009). Pulmonary suppressor of cytokine signaling-1 induced by IL-13 regulates allergic asthma phenotype. American Journal of Respiratory and Critical Care Medicine, 179(11), 992-998. [More Information]
  • Trian, T., Qi, G., Moir, L., Burgess, J., Kuo, C., King, N., Reddel, H., Black, J., Oliver, B., McParland, B. (2009). Rhinovirus-induced Exacerbations of Asthma - How is the β2-adrenoceptor Implicated? American Journal of Respiratory Cell and Molecular Biology, 43(2), 227-233. [More Information]
  • Ammit, A., Burgess, J., Zuyderduyn, S., Hughes, M., Kaur, M., Lau, J., Hirst, S. (2009). The effect of asthma therapeutics on signalling and transcriptional regulation of airway smooth muscle function. Pulmonary Pharmacology and Therapeutics, 22(5), 446-454. [More Information]
  • Burgess, J. (2009). The role of the extracellular matrix and specific growth factors in the regulation of inflammation and remodelling in asthma. Pharmacology and Therapeutics, 122(1), 19-29. [More Information]
  • Burgess, J., Ceresa, C., Johnson, S., Kanabar, V., Moir, L., Nguyen, T., Oliver, B., Schuliga, M., Ward, J. (2009). Tissue and matrix influences on airway smooth muscle function. Pulmonary Pharmacology and Therapeutics, 22(5), 379-387. [More Information]
  • Hostettler, K., Roth, M., Burgess, J., Gencay, M., Gambazzi, F., Black, J., Tamm, M., Borger, P. (2008). Airway epithelium-derived transforming growth factor-beta is a regulator of fibroblast proliferation in both fibrotic and normal subjects. Clinical and Experimental Allergy, 38(8), 1309-1317. [More Information]
  • Burgess, J., Lee, J., Ge, Q., Ramsay, E., Poniris, M., Parmentier, J., Roth, M., Johnson, P., Hunt, N., Black, J., Ammit, A. (2008). Dual ERK and phosphatidylinositol 3-kinase pathways control airway smooth muscle proliferation: Differences in asthma. Journal of Cellular Physiology, 216(3), 673-679. [More Information]
  • Oliver, B., Lim, S., Wark, P., Laza-Stanca, V., King, N., Black, J., Burgess, J., Roth, M., Johnston, S. (2008). Rhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophages. Thorax, 63(6), 519-525. [More Information]
  • Moir, L., Burgess, J., Black, J. (2008). Transforming growth factor β1 increases fibronectin deposition through integrin receptor α5β1 on human airway smooth muscle. Journal of Allergy and Clinical Immunology, 121(4), 1034-1039. [More Information]
  • Zuyderduyn, S., Sukkar, M., Fust, A., Dhaliwal, S., Burgess, J. (2008). Treating asthma means treating airway smooth muscle cells. European Respiratory Journal, 32(2), 265-274. [More Information]
  • Burgess, J., Moir, L. (2007). Airway Remodeling: Effect of Current and Future Asthma Therapies. Current Respiratory Medicine Reviews, 3(4), 297-308.
  • Matsumoto, H., Moir, L., Oliver, B., Burgess, J., Roth, M., Black, J., McParland, B. (2007). Comparison of gel contraction mediated by airway smooth muscle cells from patients with and without asthma. Thorax, 62(10), 848-854. [More Information]
  • Matsumoto, H., Moir, L., Oliver, B., Burgess, J., Roth, M., Black, J., McParland, B. (2007). Comparison of gel contraction mediated by asthmatic and non-asthmatic airway smooth muscle cells. Thorax, 62(10), 848-854. [More Information]
  • Borger, P., Matsumoto, H., Boustany, S., Gencay, M., Burgess, J., King, G., Black, J., Tamm, M., Roth, M. (2007). Disease-specific expression and regulation of CCAAT/enhancer-binding proteins in asthma and chronic obstructive pulmonary disease. Journal of Allergy and Clinical Immunology. [More Information]
  • Burgess, J., Oliver, B., Poniris, M., Ge, Q., Boustany, S., Cox, N., Moir, L., Johnson, P., Black, J. (2006). A phosphodiesterase 4 inhibitor inhibits matrix protein deposition in airways in vitro. Journal of Allergy and Clinical Immunology, 118(3), 649-657. [More Information]
  • Burgess, J., Ge, Q., Poniris, M., Boustany, S., Twigg, S., Black, J., Johnson, P. (2006). Connective tissue growth factor and vascular endothelial growth factor from airway smooth muscle interact with the extracellular matrix. American Journal of Physiology: Lung Cellular and Molecular Physiology, 290(1), L153-L161. [More Information]
  • Johnson, P., Burgess, J., Ge, Q., Poniris, M., Boustany, S., Twigg, S., Black, J. (2006). Connective tissue growth factor induces extracellular matrix in asthmatic airway smooth muscle. American Journal of Respiratory and Critical Care Medicine, 173(1), 32-41. [More Information]
  • Zhong, J., Gencay, M., Bubendorf, L., Burgess, J., Parsons, H., Robinson, B., Tamm, M., Black, J., Roth, M. (2006). ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells. Journal of Cellular Physiology, 207(2), 540-552. [More Information]
  • Chan, V., Burgess, J., Ratoff, J., O'Connor, B., Greenough, A., Lee, T., Hirst, S. (2006). Extracellular matrix regulates enhanced eotaxin expression in asthmatic airway smooth muscle cells. American Journal of Respiratory and Critical Care Medicine, 174(4), 379-385.
  • Oliver, B., Johnston, S., Baraket, M., Burgess, J., King, N., Roth, M., Lim, S., Black, J. (2006). Increased proinflammatory responses from asthmatic human airway smooth muscle cells in response to rhinovirus infection. Respiratory Research, 7, 71-71. [More Information]
  • Ammit, A., Moir, L., Oliver, B., Hughes, M., Alkhouri, H., Ge, Q., Burgess, J., Black, J., Roth, M. (2006). The effect of IL-6 trans-signaling on the pro-remodeling phenotype of airway smooth muscle. American Journal of Physiology: Lung Cellular and Molecular Physiology, 292(1), L199-L206. [More Information]
  • Burgess, J., Blake, A., Boustany, S., Johnson, P., Armour, C., Black, J., Hunt, N., Hughes, M. (2005). CD40 and OX40 ligand are increased on stimulated asthmatic airway smooth muscle. Journal of Allergy and Clinical Immunology, 115(2), 302-308. [More Information]
  • Burgess, J. (2005). Connective tissue growth factor: A role in airway remodelling in asthma? Clinical and Experimental Pharmacology and Physiology, 32(11), 988-994.
  • Black, J., Ge, Q., Boustany, S., Johnson, P., Poniris, M., Glanville, A., Oliver, B., Moir, L., Burgess, J. (2005). In vitro studies of lymphangioleiomyomatosis. European Respiratory Journal, 26(4), 569-576. [More Information]
  • Johnson, P., Burgess, J. (2004). Airway Smooth Muscle And Fibroblasts In The Pathogenesis Of Asthma. Current Allergy and Asthma Reports, 4(2), 102-108.
  • Hostettler, K., Roth, M., Burgess, J., Johnson, P., Glanville, A., Tamm, M., Black, J., Borger, P. (2004). Cyclosporine A Mediates Fibroproliferation Through Epithelial Cells. Transplantation, 77(12), 1886-1893.
  • Burgess, J., Carlin, S., Pack, R., Arndt, G., Au, W., Black, J., Johnson, P., Hunt, N. (2004). Detection And Characterization Of Ox40 Ligand Expression In Human Airway Smooth Muscle Cells: A Possible Role In Asthma? Journal of Allergy and Clinical Immunology, 113(4), 683-9. [More Information]
  • Roth, M., Johnson, P., Borger, P., Bihl, M., Rudiger, J., King, G., Ge, Q., Hostettler, K., Burgess, J., Black, J., et al (2004). Dysfunctional Interaction Of C/EBPα And The Glucocorticoid Receptor In Asthmatic Bronchial Smooth-Muscle Cells. New England Journal of Medicine, 351(6), 560-574.
  • Johnson, P., Burgess, J., Underwood, A., Au, W., Poniris, M., Tamm, M., Ge, Q., Roth, M., Black, J. (2004). Extracellular Matrix Proteins Modulate Asthmatic Airway Smooth Muscle Cell Proliferation Via An Autocrine Mechanism. Journal of Allergy and Clinical Immunology, 113(4), 690-6. [More Information]
  • Burgess, J., Ge, Q., Boustany, S., Black, J., Johnson, P. (2004). Increased Sensitivity Of Asthmatic Airway Smooth Muscle Cells To Prostaglandin E2 Might Be Mediated By Increased Numbers Of E-Prostanoid Receptors. Journal of Allergy and Clinical Immunology, 113(5), 876-881. [More Information]
  • Black, J., Burgess, J., Johnson, P. (2003). Airway smooth muscle - its relationship to the extracellular matrix. Respiratory Physiology and Neurobiology, 137(2-3), 339-346.
  • Burgess, J., Johnson, P., Ge, Q., Au, W., Poniris, M., McParland, B., King, G., Roth, M., Black, J. (2003). Expression of connective tissue growth factor in asthmatic airway smooth muscle cells. American Journal of Respiratory and Critical Care Medicine, 167(1), 71-77.
  • Chambers, L., Black, J., Ge, Q., Carlin, S., Au, W., Poniris, M., Thompson, J., Johnson, P., Burgess, J. (2003). PAR-2 activation, PGE2, and COX-2 in human asthmatic and nonasthmatic airway smooth muscle cells. American Journal of Physiology: Lung Cellular and Molecular Physiology, 285(3), L619-L627.
  • Burgess, J., McParland, B. (2002). Analysis of gene expression. Methods in Enzymology, 356(22), 259-270.
  • Roth, M., Johnson, P., Rudiger, J., King, G., Ge, Q., Burgess, J., Anderson, G., Tamm, M., Black, J. (2002). Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling. The Lancet, 360(9342), 1293-1299.
  • Johnson, P., Roth, M., Tamm, M., Hughes, M., Ge, Q., King,, G., Burgess, J., Black, J. (2001). Airway smooth muscle cell proliferation is increased in asthma. American Journal of Respiratory and Critical Care Medicine, 164(3), 474-477.
  • Burgess, J. (2001). Gene expression studies using Microarrays. Clinical and Experimental Pharmacology and Physiology, 28, 321-328.
  • Burgess, J. (2001). Molecular mechanisms of drug-induced thrombocytopenia. Current Opinion In Hematology, 8, 294-298.

2014

  • Grafton, K., Moir, L., Black, J., Hansbro, N., Hansbro, P., Burgess, J., Oliver, B. (2014). LF-15 and T7, Synthetic Peptides Derived from Tumstatin, Attenuate Aspects of Airway Remodelling in a Murine Model of Chronic OVA-Induced Allergic Airway Disease. PLoS One, 9(1), 1-6. [More Information]
  • Tjin, G., Xu, P., Kable, S., Kable, E., Burgess, J. (2014). Quantification of collagen I in airway tissues using second harmonic generation. Journal of Biomedical Optics, 19(3), 1-10. [More Information]

2013

  • Van Ly, D., Faiz, A., Jenkins, C., Crossett, B., Black, J., McParland, B., Burgess, J., Oliver, B. (2013). Characterising the Mechanism of Airway Smooth Muscle B2 Adrenoceptor Desensitization by Rhinovirus Infected Bronchial Epithelial Cells. PLoS One, 8(2), 1-17. [More Information]
  • Chen, L., Ge, Q., Black, J., Deng, L., Burgess, J., Oliver, B. (2013). Differential Regulation of Extracellular Matrix and Soluble Fibulin-1 Levels by TGF-β1 in Airway Smooth Muscle Cells. PLoS One, 8(6), 1-8. [More Information]
  • Krimmer, D., Ichimaru, Y., Burgess, J., Black, J., Oliver, B. (2013). Exposure to Biomass Smoke Extract Enhances Fibronectin Release from Fibroblasts. PLoS One, 8(12), 1-10. [More Information]
  • Wright, D., Trian, T., Siddiqui, S., Pascoe, C., Ojo, O., Johnson, J., Dekkers, B., Dakshinamurti, S., Bagchi, R., Burgess, J., et al (2013). Functional phenotype of airway myocytes from asthmatic airways. Pulmonary Pharmacology & Therapeutics, 26(1), 95-104. [More Information]
  • Van Ly, D., De Pedro, M., James, P., Morgan, L., Black, J., Burgess, J., Oliver, B. (2013). Inhibition of phosphodiesterase 4 modulates cytokine induction from toll like receptor activated, but not rhinovirus infected, primary human airway smooth muscle. Respiratory Research (Online), 14(127), 1-11. [More Information]
  • Wright, D., Trian, T., Siddiqui, S., Pascoe, C., Johnson, J., Dekkers, B., Dakshinamurti, S., Bagchi, R., Burgess, J., Kanabar, V., et al (2013). Phenotype modulation of airway smooth muscle in asthma. Pulmonary Pharmacology & Therapeutics, 26(1), 42-49. [More Information]
  • Faiz, A., Tjin, G., Harkness, L., Weckmann, M., Bao, B., Black, J., Oliver, B., Burgess, J. (2013). The Expression and Activity of Cathepsins D, H and K in Asthmatic Airways. PLoS One, 8(3), 1-8. [More Information]
  • Reddel, C., Cultrone, D., Rnjak-Kovacina, J., Weiss, A., Burgess, J. (2013). Tropoelastin modulates TGF-B1-induced expression of VEGF and CTGF in airway smooth muscle cells. Matrix biology: journal of the International Society for Matrix Biology, 32(7-8), 407-413. [More Information]

2012

  • Alrashdan, Y., Alkhouri, H., Chen, E., Lalor, D., Poniris, M., Henness, S., Brightling, C., Burgess, J., Armour, C., Ammit, A., Hughes, M. (2012). Asthmatic airway smooth muscle CXCL10 production: mitogen-activated protein kinase JNK involvement. American Journal of Physiology: Lung Cellular and Molecular Physiology, 302(10), L118-L1127. [More Information]
  • Niimi, K., Ge, Q., Moir, L., Ammit, A., Trian, T., Burgess, J., Black, J., Oliver, B. (2012). B2-Agonists upregulate PDE4 mRNA but not protein or activity in human airway smooth muscle cells from asthmatic and nonasthmatic volunteers. American Journal of Physiology: Lung Cellular and Molecular Physiology, 302(3), L334-L342. [More Information]
  • Ge, Q., Poniris, M., Moir, L., Black, J., Burgess, J. (2012). Combined Beta-Agonists and Corticosteroids Do Not Inhibit Extracellular Matrix Protein Production In Vitro. Journal of Allergy, 2012, 1-7. [More Information]
  • Bosse, Y., Vagula, M., Pun, M., Black, J., Berger, P., Rawding, R., Burgess, J., Adner, M., Oliver, B., Marthan, R. (2012). Comments on Point:Counterpoint: Alterations in airway smooth muscle phenotype do/do not cause airway hyperresponsiveness in asthma. Journal of Applied Physiology, 113(5), 844-846. [More Information]
  • Reddel, C., Weiss, A., Burgess, J. (2012). Elastin in asthma. Pulmonary Pharmacology & Therapeutics, 25(2), 144-153. [More Information]
  • Faiz, A., Burgess, J. (2012). How Can Microarrays Unlock Asthma? Journal of Allergy, 2012, 1-15. [More Information]
  • Baraket, M., Oliver, B., Burgess, J., Lim, S., King, G., Black, J. (2012). Is low dose inhaled corticosteroid therapy as effective for inflammation and remodeling in asthma? A randomized, parallel group study. Respiratory Research (Online), 13(2 February 2012), 1-11. [More Information]
  • Weckmann, M., Moir, L., Heckman, C., Black, J., Oliver, B., Burgess, J. (2012). Lamstatin - a novel inhibitor of lymphangiogenesis derived from collagen IV. Journal of Cellular and Molecular Medicine, 16(12), 3062-3073. [More Information]
  • Burgess, J., Weckmann, M. (2012). Matrikines and the lungs. Pharmacology & Therapeutics, 134(3), 317-337. [More Information]
  • Krimmer, D., Burgess, J., Wooi, T., Black, J., Oliver, B. (2012). Matrix Proteins from Smoke Exposed Fibroblasts are Pro-proliferative. American Journal of Respiratory Cell and Molecular Biology, 46(1), 34-39. [More Information]
  • Van Ly, D., Burgess, J., Brock, T., Lee, T., Black, J., Oliver, B. (2012). Prostaglandins but not leukotrienes alter extracellular matrix protein deposition and cytokine release in primary human airway smooth muscle cells and fibroblasts. American Journal of Physiology: Lung Cellular and Molecular Physiology, 303(3), L239-L250. [More Information]
  • Ichimaru, Y., Krimmer, D., Burgess, J., Black, J., Oliver, B. (2012). TGF-B enhances deposition of perlecan from COPD airway smooth muscle. American Journal of Physiology: Lung Cellular and Molecular Physiology, 302(3), L325-L333. [More Information]
  • Ge, Q., Moir, L., Trian, T., Niimi, K., Poniris, M., Shepherd, P., Black, J., Oliver, B., Burgess, J. (2012). The phosphoinositide 3'-kinase p110d modulates contractile protein production and IL-6 release in human airway smooth muscle. Journal of Cellular Physiology, 227(8), 3044-3052. [More Information]
  • Seidel, P., Alkhouri, H., Lalor, D., Burgess, J., Armour, C., Hughes, M. (2012). Thiazolidinediones inhibit airway smooth muscle release of the chemokine CXCL10: in vitro comparison with current asthma therapies. Respiratory Research (Online), 13, 1-13. [More Information]

2011

  • Burgess, J. (2011). Current and future models for understanding airway diseases. Pulmonary Pharmacology and Therapeutics, 24(5), 443-443. [More Information]
  • Moir, L., Ng, H., Poniris, M., Santa, T., Burgess, J., Oliver, B., Krymskaya, V., Black, J. (2011). Doxycycline inhibits matrix metalloproteinase-2 secretion from TSC2-null mouse embryonic fibroblasts and lymphangioleiomyomatosis cells. British Journal of Pharmacology, 164(1), 83-92. [More Information]
  • Van Ly, D., King, N., Moir, L., Burgess, J., Black, J., Oliver, B. (2011). Effects of β2 Agonists, Corticosteroids, and Novel Therapies on Rhinovirus-Induced Cytokine Release and Rhinovirus Replication in Primary Airway Fibroblasts. Journal of Allergy, 2011 (Article ID 457169), 1-11. [More Information]
  • Moir, L., Trian, T., Ge, Q., Shepherd, P., Burgess, J., Oliver, B., Black, J. (2011). Phosphatidylinositol 3-Kinase Isoform-Specific Effects in Airway Mesenchymal Cell Function. Journal of Pharmacology and Experimental Therapeutics, 337(2), 557-566. [More Information]
  • Kuo, C., Lim, S., King, N., Bartlett, N., Walton, R., Zhu, J., Glanville, N., Aniscenko, J., Johnston, S., Burgess, J., Black, J., Oliver, B. (2011). Rhinovirus infection induces expression of airway remodelling factors in vitro and in vivo. Respirology, 16(2), 367-377. [More Information]
  • Kuo, C., Lim, S., King, N., Johnston, S., Burgess, J., Black, J., Oliver, B. (2011). Rhinovirus infection induces extracellular matrix protein deposition in asthmatic and nonasthmatic airway smooth muscle cells. American Journal of Physiology: Lung Cellular and Molecular Physiology, 300(6), L951-L957. [More Information]
  • Trian, T., Burgess, J., Niimi, K., Moir, L., Ge, Q., Berger, P., Liggett, S., Black, J., Oliver, B. (2011). β(2)-Agonist Induced cAMP Is Decreased in Asthmatic Airway Smooth Muscle Due to Increased PDE4D. PLoS One, 6(5), e20000-1-e20000-7. [More Information]

2010

  • Lau, J., Oliver, B., Moir, L., Black, J., Burgess, J. (2010). Differential expression of peroxisome proliferator activated receptor gamma and cyclin D1 does not affect proliferation of asthma- and non-asthma-derived airway smooth muscle cells. Respirology, 15(2), 303-312. [More Information]
  • Lau, J., Oliver, B., Baraket, M., Beckett, E., Hansbro, N., Moir, L., Wilton, S., Williams, C., Foster, P., Hansbro, P., Black, J., Burgess, J. (2010). Fibulin-1 is increased in asthma - a novel mediator of airway remodeling? PLoS One, 5(10 (e13360)), 1-13. [More Information]
  • Burgess, J., Boustany, S., Moir, L., Weckmann, M., Lau, J., Grafton, K., Baraket, M., Hansbro, P., Hansbro, N., Foster, P., Black, J., Oliver, B. (2010). Reduction of Tumstatin in Asthmatic Airways Contributes to Angiogenesis, Inflammation and Hyperresponsiveness. American Journal of Respiratory and Critical Care Medicine, 181(2), 106-115. [More Information]
  • Ge, Q., Moir, L., Black, J., Oliver, B., Burgess, J. (2010). TGFBeta1 Induces IL-6 and Inhibits IL-8 Release in Human Bronchial Epithelial Cells: The Role of Smad2/3. Journal of Cellular Physiology, 225(3), 846-854. [More Information]
  • Burgess, J. (2010). The Extracellular Matrix: Friend or Foe in Airway Disease? Minerva Pneumologica: A Journal on Diseases of the Respiratory System, 49, 219-236.

2009

  • Bailey, S., Boustany, S., Burgess, J., Hirst, S., Sharma, H., Simcock, D., Suravaram, P., Weckmann, M. (2009). Airway vascular reactivity and vascularisation in human chronic airway disease. Pulmonary Pharmacology and Therapeutics, 22(5), 417-425. [More Information]
  • Krimmer, D., Loseli, M., Hughes, M., Oliver, B., Moir, L., Hunt, N., Black, J., Burgess, J. (2009). CD40 and OX40 ligand are differentially regulated on asthmatic airway smooth muscle. Allergy, 64, 1074-1082. [More Information]
  • Fukuyama, S., Nakano, T., Matsumoto, T., Oliver, B., Burgess, J., Moriwaki, A., Tanaka, K., Kubo, M., Hoshino, T., Tanaka, H., Black, J., et al (2009). Pulmonary suppressor of cytokine signaling-1 induced by IL-13 regulates allergic asthma phenotype. American Journal of Respiratory and Critical Care Medicine, 179(11), 992-998. [More Information]
  • Trian, T., Qi, G., Moir, L., Burgess, J., Kuo, C., King, N., Reddel, H., Black, J., Oliver, B., McParland, B. (2009). Rhinovirus-induced Exacerbations of Asthma - How is the β2-adrenoceptor Implicated? American Journal of Respiratory Cell and Molecular Biology, 43(2), 227-233. [More Information]
  • Ammit, A., Burgess, J., Zuyderduyn, S., Hughes, M., Kaur, M., Lau, J., Hirst, S. (2009). The effect of asthma therapeutics on signalling and transcriptional regulation of airway smooth muscle function. Pulmonary Pharmacology and Therapeutics, 22(5), 446-454. [More Information]
  • Burgess, J. (2009). The role of the extracellular matrix and specific growth factors in the regulation of inflammation and remodelling in asthma. Pharmacology and Therapeutics, 122(1), 19-29. [More Information]
  • Burgess, J., Ceresa, C., Johnson, S., Kanabar, V., Moir, L., Nguyen, T., Oliver, B., Schuliga, M., Ward, J. (2009). Tissue and matrix influences on airway smooth muscle function. Pulmonary Pharmacology and Therapeutics, 22(5), 379-387. [More Information]

2008

  • Hostettler, K., Roth, M., Burgess, J., Gencay, M., Gambazzi, F., Black, J., Tamm, M., Borger, P. (2008). Airway epithelium-derived transforming growth factor-beta is a regulator of fibroblast proliferation in both fibrotic and normal subjects. Clinical and Experimental Allergy, 38(8), 1309-1317. [More Information]
  • Black, J., Burgess, J., Oliver, B., Moir, L. (2008). Altered properties of airway smooth muscle in asthma. In Chung, K. (Eds.), Airway Smooth Muscle in Asthma and COPD: Biology and Pharmacology, (pp. 181-199). United Kingdom: John Wiley & Sons.
  • Burgess, J., Lee, J., Ge, Q., Ramsay, E., Poniris, M., Parmentier, J., Roth, M., Johnson, P., Hunt, N., Black, J., Ammit, A. (2008). Dual ERK and phosphatidylinositol 3-kinase pathways control airway smooth muscle proliferation: Differences in asthma. Journal of Cellular Physiology, 216(3), 673-679. [More Information]
  • Oliver, B., Lim, S., Wark, P., Laza-Stanca, V., King, N., Black, J., Burgess, J., Roth, M., Johnston, S. (2008). Rhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophages. Thorax, 63(6), 519-525. [More Information]
  • Moir, L., Burgess, J., Black, J. (2008). Transforming growth factor β1 increases fibronectin deposition through integrin receptor α5β1 on human airway smooth muscle. Journal of Allergy and Clinical Immunology, 121(4), 1034-1039. [More Information]
  • Zuyderduyn, S., Sukkar, M., Fust, A., Dhaliwal, S., Burgess, J. (2008). Treating asthma means treating airway smooth muscle cells. European Respiratory Journal, 32(2), 265-274. [More Information]

2007

  • Burgess, J., Moir, L. (2007). Airway Remodeling: Effect of Current and Future Asthma Therapies. Current Respiratory Medicine Reviews, 3(4), 297-308.
  • Matsumoto, H., Moir, L., Oliver, B., Burgess, J., Roth, M., Black, J., McParland, B. (2007). Comparison of gel contraction mediated by airway smooth muscle cells from patients with and without asthma. Thorax, 62(10), 848-854. [More Information]
  • Matsumoto, H., Moir, L., Oliver, B., Burgess, J., Roth, M., Black, J., McParland, B. (2007). Comparison of gel contraction mediated by asthmatic and non-asthmatic airway smooth muscle cells. Thorax, 62(10), 848-854. [More Information]
  • Borger, P., Matsumoto, H., Boustany, S., Gencay, M., Burgess, J., King, G., Black, J., Tamm, M., Roth, M. (2007). Disease-specific expression and regulation of CCAAT/enhancer-binding proteins in asthma and chronic obstructive pulmonary disease. Journal of Allergy and Clinical Immunology. [More Information]

2006

  • Burgess, J., Oliver, B., Poniris, M., Ge, Q., Boustany, S., Cox, N., Moir, L., Johnson, P., Black, J. (2006). A phosphodiesterase 4 inhibitor inhibits matrix protein deposition in airways in vitro. Journal of Allergy and Clinical Immunology, 118(3), 649-657. [More Information]
  • Burgess, J., Ge, Q., Poniris, M., Boustany, S., Twigg, S., Black, J., Johnson, P. (2006). Connective tissue growth factor and vascular endothelial growth factor from airway smooth muscle interact with the extracellular matrix. American Journal of Physiology: Lung Cellular and Molecular Physiology, 290(1), L153-L161. [More Information]
  • Johnson, P., Burgess, J., Ge, Q., Poniris, M., Boustany, S., Twigg, S., Black, J. (2006). Connective tissue growth factor induces extracellular matrix in asthmatic airway smooth muscle. American Journal of Respiratory and Critical Care Medicine, 173(1), 32-41. [More Information]
  • Zhong, J., Gencay, M., Bubendorf, L., Burgess, J., Parsons, H., Robinson, B., Tamm, M., Black, J., Roth, M. (2006). ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells. Journal of Cellular Physiology, 207(2), 540-552. [More Information]
  • Chan, V., Burgess, J., Ratoff, J., O'Connor, B., Greenough, A., Lee, T., Hirst, S. (2006). Extracellular matrix regulates enhanced eotaxin expression in asthmatic airway smooth muscle cells. American Journal of Respiratory and Critical Care Medicine, 174(4), 379-385.
  • Oliver, B., Johnston, S., Baraket, M., Burgess, J., King, N., Roth, M., Lim, S., Black, J. (2006). Increased proinflammatory responses from asthmatic human airway smooth muscle cells in response to rhinovirus infection. Respiratory Research, 7, 71-71. [More Information]
  • Ammit, A., Moir, L., Oliver, B., Hughes, M., Alkhouri, H., Ge, Q., Burgess, J., Black, J., Roth, M. (2006). The effect of IL-6 trans-signaling on the pro-remodeling phenotype of airway smooth muscle. American Journal of Physiology: Lung Cellular and Molecular Physiology, 292(1), L199-L206. [More Information]

2005

  • Burgess, J., Blake, A., Boustany, S., Johnson, P., Armour, C., Black, J., Hunt, N., Hughes, M. (2005). CD40 and OX40 ligand are increased on stimulated asthmatic airway smooth muscle. Journal of Allergy and Clinical Immunology, 115(2), 302-308. [More Information]
  • Burgess, J. (2005). Connective tissue growth factor: A role in airway remodelling in asthma? Clinical and Experimental Pharmacology and Physiology, 32(11), 988-994.
  • Black, J., Ge, Q., Boustany, S., Johnson, P., Poniris, M., Glanville, A., Oliver, B., Moir, L., Burgess, J. (2005). In vitro studies of lymphangioleiomyomatosis. European Respiratory Journal, 26(4), 569-576. [More Information]

2004

  • Johnson, P., Burgess, J. (2004). Airway Smooth Muscle And Fibroblasts In The Pathogenesis Of Asthma. Current Allergy and Asthma Reports, 4(2), 102-108.
  • Hostettler, K., Roth, M., Burgess, J., Johnson, P., Glanville, A., Tamm, M., Black, J., Borger, P. (2004). Cyclosporine A Mediates Fibroproliferation Through Epithelial Cells. Transplantation, 77(12), 1886-1893.
  • Burgess, J., Carlin, S., Pack, R., Arndt, G., Au, W., Black, J., Johnson, P., Hunt, N. (2004). Detection And Characterization Of Ox40 Ligand Expression In Human Airway Smooth Muscle Cells: A Possible Role In Asthma? Journal of Allergy and Clinical Immunology, 113(4), 683-9. [More Information]
  • Roth, M., Johnson, P., Borger, P., Bihl, M., Rudiger, J., King, G., Ge, Q., Hostettler, K., Burgess, J., Black, J., et al (2004). Dysfunctional Interaction Of C/EBPα And The Glucocorticoid Receptor In Asthmatic Bronchial Smooth-Muscle Cells. New England Journal of Medicine, 351(6), 560-574.
  • Johnson, P., Burgess, J., Underwood, A., Au, W., Poniris, M., Tamm, M., Ge, Q., Roth, M., Black, J. (2004). Extracellular Matrix Proteins Modulate Asthmatic Airway Smooth Muscle Cell Proliferation Via An Autocrine Mechanism. Journal of Allergy and Clinical Immunology, 113(4), 690-6. [More Information]
  • Burgess, J., Ge, Q., Boustany, S., Black, J., Johnson, P. (2004). Increased Sensitivity Of Asthmatic Airway Smooth Muscle Cells To Prostaglandin E2 Might Be Mediated By Increased Numbers Of E-Prostanoid Receptors. Journal of Allergy and Clinical Immunology, 113(5), 876-881. [More Information]
  • Burgess, J. (2004). Overview Of Microarrays In Genomic Analysis. In Ralph Rapley, Harbron Stuart (Eds.), Molecular Analysis and Genome Discovery, (pp. 127-158). UK: Nicholson Museum, University of Sydney.

2003

  • Black, J., Burgess, J., Johnson, P. (2003). Airway smooth muscle - its relationship to the extracellular matrix. Respiratory Physiology and Neurobiology, 137(2-3), 339-346.
  • Burgess, J., Johnson, P., Ge, Q., Au, W., Poniris, M., McParland, B., King, G., Roth, M., Black, J. (2003). Expression of connective tissue growth factor in asthmatic airway smooth muscle cells. American Journal of Respiratory and Critical Care Medicine, 167(1), 71-77.
  • Chambers, L., Black, J., Ge, Q., Carlin, S., Au, W., Poniris, M., Thompson, J., Johnson, P., Burgess, J. (2003). PAR-2 activation, PGE2, and COX-2 in human asthmatic and nonasthmatic airway smooth muscle cells. American Journal of Physiology: Lung Cellular and Molecular Physiology, 285(3), L619-L627.

2002

  • Burgess, J., McParland, B. (2002). Analysis of gene expression. Methods in Enzymology, 356(22), 259-270.
  • Roth, M., Johnson, P., Rudiger, J., King, G., Ge, Q., Burgess, J., Anderson, G., Tamm, M., Black, J. (2002). Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling. The Lancet, 360(9342), 1293-1299.

2001

  • Johnson, P., Roth, M., Tamm, M., Hughes, M., Ge, Q., King,, G., Burgess, J., Black, J. (2001). Airway smooth muscle cell proliferation is increased in asthma. American Journal of Respiratory and Critical Care Medicine, 164(3), 474-477.
  • Burgess, J. (2001). Gene expression studies using Microarrays. Clinical and Experimental Pharmacology and Physiology, 28, 321-328.
  • Burgess, J. (2001). Molecular mechanisms of drug-induced thrombocytopenia. Current Opinion In Hematology, 8, 294-298.

To update your profile click here. For support on your academic profile contact .